These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35685428)

  • 21. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of potential biomarkers and candidate small molecule drugs in glioblastoma.
    Lu WC; Xie H; Yuan C; Li JJ; Li ZY; Wu AH
    Cancer Cell Int; 2020; 20():419. PubMed ID: 32874133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
    Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.
    Dong C; Fan W; Fang S
    J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening seven hub genes associated with prognosis and immune infiltration in glioblastoma.
    Zhang Y; Fan H; Zou C; Wei F; Sun J; Shang Y; Chen L; Wang X; Hu B
    Front Genet; 2022; 13():924802. PubMed ID: 36035134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of carboxypeptidase Q and its methylation in glioblastoma.
    Liu Q; Wang R; Li Z; Peng Y; Qin W; Peng XM; Liu ZG
    Transl Cancer Res; 2023 May; 12(5):1073-1087. PubMed ID: 37304538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction network of immune-associated genes affecting the prognosis of patients with glioblastoma.
    Hou X; Chen J; Zhang Q; Fan Y; Xiang C; Zhou G; Cao F; Yao S
    Exp Ther Med; 2021 Jan; 21(1):61. PubMed ID: 33365061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of Potential Glioblastoma Multiforme-Related miRNA-mRNA Regulatory Network.
    Lou W; Ding B; Xu L; Fan W
    Front Mol Neurosci; 2019; 12():66. PubMed ID: 30971889
    [No Abstract]   [Full Text] [Related]  

  • 30. Establishment and validation of an immune-based prognostic score model in glioblastoma.
    Qin Z; Zhang X; Chen Z; Liu N
    Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma.
    Yin W; Tang G; Zhou Q; Cao Y; Li H; Fu X; Wu Z; Jiang X
    Front Genet; 2019; 10():419. PubMed ID: 31130992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma.
    Jia D; Lin W; Tang H; Cheng Y; Xu K; He Y; Geng W; Dai Q
    Aging (Albany NY); 2019 Aug; 11(15):5579-5592. PubMed ID: 31395792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas.
    Huang S; Song Z; Zhang T; He X; Huang K; Zhang Q; Shen J; Pan J
    Front Immunol; 2020; 11():585034. PubMed ID: 33193404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology.
    Cui K; Chen JH; Zou YF; Zhang SY; Wu B; Jing K; Li LW; Xia L; Sun C; Dong YL
    Technol Cancer Res Treat; 2021; 20():1533033821990368. PubMed ID: 34018447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
    Jin Y; Yang Y
    Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
    Kong Y; Feng ZC; Zhang YL; Liu XF; Ma Y; Zhao ZM; Huang B; Chen AJ; Zhang D; Thorsen F; Wang J; Yang N; Li XG
    Front Immunol; 2020; 11():1281. PubMed ID: 32765489
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of gene biomarkers and immune cell infiltration characteristics in rectal cancer.
    Wen L; Han Z; Du Y
    J Gastrointest Oncol; 2021 Jun; 12(3):964-980. PubMed ID: 34295549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.